OXiGENE

0.7031

-0.0269-3.68%

成交量：16.96萬

成交額：11.92萬

市值：- -

市盈率：- -

高：0.7400

開：0.7400

低：0.6995

收：0.7300

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

OXiGENE

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.oxigene.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

OxiGene is a biotechnology company developing small-molecule therapeutics to treat cancer and certain eye diseases. As of Dec 31 2006, Co. had two therapeutic product candidates in clinical and preclinical development.

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/OXGN/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OXGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OXGN\",,,,,undefined,":{"symbol":"OXGN","market":"US","secType":"STK","nameCN":"OXiGENE","latestPrice":0.7031,"timestamp":1466193600000,"preClose":0.73,"halted":0,"volume":169586,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-0.0269,"latestTime":"06-17 16:00:00 EDT","open":0.74,"high":0.74,"low":0.6995,"amount":119235.9166,"amplitude":0.055479,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.73,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OXGN\",,,,,undefined,":{"symbol":"OXGN","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":0.74,"amplitude":0.055479,"preClose":0.73,"low":0.6995,"week52Low":0.49,"pbRate":"--","week52High":1.55,"institutionHeld":0.1998,"latestPrice":0.7031,"eps":0,"divideRate":0,"volume":169586,"delay":0,"open":0.74},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.oxigene.com","compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"OxiGene is a biotechnology company developing small-molecule therapeutics to treat cancer and certain eye diseases. As of Dec 31 2006, Co. had two therapeutic product candidates in clinical and preclinical development.","exchange":"NASDAQ","name":"OXiGENE","nameEN":"OXiGENE, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OXGN\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OXGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-05-09","symbol":"OXGN","expectedEps":-0.19,"name":"OXiGENE","time":"","type":"earning","dateTimestamp":1462766400000,"reportTimeType":"","actualEps":-0.13},{"market":"US","date":"2016-03-28","symbol":"OXGN","expectedEps":-0.14,"name":"OXiGENE","time":"","type":"earning","dateTimestamp":1459137600000,"reportTimeType":"","actualEps":-0.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OXGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OXGN\",market:\"US\",delay:false,,,undefined,":{}}}